Further functional investigations demonstrated that Kif2c inhibition markedly enhances the sensitivity of HCC cells to glycolysis inhibitors, suggesting that Kif2c may serve as a critical node within a metabolic-epigenetic crosstalk regulatory network. The gene discussed is KIF2C; the disease is hepatocellular carcinoma.